Masatake Kurita

Summary

Affiliation: Fukushima Medical University
Country: Japan

Publications

  1. ncbi request reprint Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells
    Masatake Kurita
    Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960 1295, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 31:600-4. 2007
  2. ncbi request reprint Effects of fluvoxamine on behavioral and psychological symptoms of dementia in Alzheimer's disease: a report of three cases
    Masatake Kurita
    Kotokukai Sato Hospital, Yamagata, 960 2156, Japan
    Fukushima J Med Sci 52:143-8. 2006
  3. ncbi request reprint Lithium chloride at a therapeutic concentration reduces Ca2+ response in protein kinase C down-regulated human astrocytoma cells
    Masatake Kurita
    Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Hikarigaoka 1, Fukushima, Japan
    Eur J Pharmacol 442:17-22. 2002
  4. pmc Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study
    Masatake Kurita
    Sato Hospital, Koutokukai, Nanyo, Yamagata, Japan
    PLoS ONE 7:e39212. 2012
  5. ncbi request reprint Case of bipolar disorder successfully stabilized with clonazepam, valproate and lithium after numerous relapses for 47 years
    Hirobumi Mashiko
    Psychiatry Clin Neurosci 58:340-1. 2004

Collaborators

  • Hirobumi Mashiko
  • Norihiro Miyashita
  • Koji Ohtomo
  • Shin ichi Niwa
  • Hisayoshi Shirakawa
  • Mikio Hashimoto

Detail Information

Publications5

  1. ncbi request reprint Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells
    Masatake Kurita
    Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960 1295, Japan
    Prog Neuropsychopharmacol Biol Psychiatry 31:600-4. 2007
    ..VPA-induced reduction of PKC activity and [Ca(2+)](i) elevation may play a role in the treatment of mood disorder...
  2. ncbi request reprint Effects of fluvoxamine on behavioral and psychological symptoms of dementia in Alzheimer's disease: a report of three cases
    Masatake Kurita
    Kotokukai Sato Hospital, Yamagata, 960 2156, Japan
    Fukushima J Med Sci 52:143-8. 2006
    ..To report 3 cases of severe behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) with fluvoxamine treatment and to discuss the treatment implications for use of the drug...
  3. ncbi request reprint Lithium chloride at a therapeutic concentration reduces Ca2+ response in protein kinase C down-regulated human astrocytoma cells
    Masatake Kurita
    Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Hikarigaoka 1, Fukushima, Japan
    Eur J Pharmacol 442:17-22. 2002
    ....
  4. pmc Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study
    Masatake Kurita
    Sato Hospital, Koutokukai, Nanyo, Yamagata, Japan
    PLoS ONE 7:e39212. 2012
    ..Our results show that plasma BDNF levels are associated with clinical outcomes during the treatment of depression. We suggest that plasma BDNF could potentially serve as a prognostic biomarker for depression, predicting clinical outcome...
  5. ncbi request reprint Case of bipolar disorder successfully stabilized with clonazepam, valproate and lithium after numerous relapses for 47 years
    Hirobumi Mashiko
    Psychiatry Clin Neurosci 58:340-1. 2004